|
||||
|
Historical or traditional use (may or may not be supported by scientific studies): Native Americans used the soapy leaves from yucca for numerous conditions. Poultices or baths were used for skin sores and other diseases as well as for sprains. Inflammation of all sorts, including joint inflammations and bleeding, were also treated with yucca. It is also reported that Native Americans washed their hair with yucca to fight dandruff and hair loss. Research continues on the virtues of this herb
in combating certain forms cancer. It has been shown effective in inhibiting almost
completely sarcoma 180 and Ehrlich carcinoma, according to the prestigious Sloan-Kettering
Cancer Research Institute. According to Oncology (22:57),
extract of Yucca strongly inhibited Lewis lung mouse tumor and the Friend
virus leukemia in mice by some
Doctors Bernard Bellew and Robert Bingham conducted studies at the National Arthritis Medical Clinic with 101 arthritic patients, giving half Yucca tablets and the other half placebos (look-alikes). Those receiving four Yucca tablets, 61% reported feeling less pain, stiffness and swelling in their arthritis than those on the placebo. A double-blind trial indicated a saponin extract of Yucca demonstrated a positive therapeutic effect on osteoarthritis, according to J. Applied Nutrition.
Active constituents: The
saponins from yucca are the major constituents in the plant. They have both
a water- and fat-soluble end and therefore act like soap. One preliminary
trial reportedly found benefit for patients with osteoarthritis and
rheumatoid arthritis.1 The authors of the study speculate that yucca
saponins may block release of toxins from the intestines that inhibit normal
formation of cartilage. This has yet to be proven in human pharmacological
studies. An extract of one species of yucca has been found to fight melanoma
cells in test tube studies.2 Clinical trials are lacking to prove whether
yucca may be useful for treating cancer in humans.
Capsule: Four capsules twice daily.
products | articles menu | news | home |